Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Catalyst Pharmaceuticals Inc’s current trading price is -6.06% away from its 52-week high, while its distance from the 52-week low is 73.83%. The stock’s price range during this period has varied between $13.12 and $24.27. The company, active in the Healthcare sector, saw a trading volume of around 3.09 million for the day, considerably higher average daily volume of 0.92 million observed over the last three months.
The stock market performance of Catalyst Pharmaceuticals Inc has been very steady. Over the last year, the company’s stock hit its highest at $24.27 on 11/08/24, while the lowest price during the same time frame was $13.12, recorded on 02/08/24.
How Financial Performance Impacts Market Capitalization
Catalyst Pharmaceuticals Inc (CPRX) has experienced a quarterly rise of 13.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.72B and boasts a workforce of 167 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 21.06, with a change in price of +2.89. Similarly, Catalyst Pharmaceuticals Inc recorded 951,511 in trading volume during the last 100 days, posting a change of +14.52%.
How CPRX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CPRX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CPRX Stock Stochastic Average
As of today, the raw stochastic average of Catalyst Pharmaceuticals Inc over the last 50 days is at 71.29%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 75.26%. Further, the company’s Stochastic %K and %D values for the last 20 days were 28.13% and 21.20%, respectively.
CPRX Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 9.25%. However, over the past six months, we’ve seen a weaker performance of 47.48%. The price of CPRX fallen by 3.54% over the last 30 days. And in the last five days, it has surged by 9.25%.
